Skip to main content
Explore URMC

menu

A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma

Research Question:
Do the drugs elotuzumab, polmalidomide, bortezomib or dexamethasone help people with multiple myeloma?

Basic Study Information

Purpose:
This research study is studying a combination of study drugs as a possible treatment for relapsed and refractory Multiple Myeloma. The interventions involved in this study are elotuzumab, pomalidomide, bortezomib, dexamethasone.

Location: University of Rochester

Lead Researcher (Principal Investigator)

Lead Researcher: Brea Lipe

Study Contact Information

Study Coordinator: Brea C. Lipe, MD
Phone: (585) 275-5823
Email: ayee1@mgh.harvard.edu

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search